Literature DB >> 32681980

How autoinflammation may turn into autoimmune inflammation: Insights from monogenetic and complex IL-1 mediated auto-inflammatory diseases.

N M Ter Haar1, M H A Jansen2, J F Frenkel2, S J Vastert3.   

Abstract

IL-1 mediated auto-inflammatory diseases are characterised by episodes of unexplained fever, generalized and localized inflammation. The characteristic symptoms predominantly result from exaggerated activation of innate immune pathways. However, in some patients with typical IL-1 mediated diseases, chronic disease manifestations develop in the absence of acute inflammation, suggesting the involvement of adaptive immune pathways. We discuss clinical observations as well as novel insights in how chronic activation of innate immune pathways can lead to auto-immune disease features in patients with auto-inflammatory diseases and how we need to better understand these sequelae in order to improve treatment strategies.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Auto-immune inflammation; Auto-inflammation; Mechanisms of disease

Year:  2020        PMID: 32681980     DOI: 10.1016/j.clim.2020.108538

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  3 in total

Review 1.  Implications of SARS-CoV-2 Infection in Systemic Juvenile Idiopathic Arthritis.

Authors:  Laura Marinela Ailioaie; Constantin Ailioaie; Gerhard Litscher
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

2.  Autoinflammation leading to autoimmunity in adult-onset Still's disease: more than simple coincidence?

Authors:  Larissa Valor-Méndez; Bernhard Manger; Alexander Cavallaro; Stephan Achenbach; Georg Schett; Jürgen Rech
Journal:  Eur J Med Res       Date:  2021-09-20       Impact factor: 2.175

Review 3.  Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases.

Authors:  Zoltán Szekanecz; Iain B McInnes; Georg Schett; Szilvia Szamosi; Szilvia Benkő; Gabriella Szűcs
Journal:  Nat Rev Rheumatol       Date:  2021-08-02       Impact factor: 20.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.